secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVENUE THERAPEUTICS, INC. (ATXI)
CIK:        0001644963
Form:       8-K
Filed at:   2023-02-01T23:59:59+00:00
Accession:  0001104659-23-008989
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avenue Therapeutics closes $3.25M equity raise; existing warrants repriced to $1.55
--------------------------------------------------------------------------------

- Raised ~$3.25M gross via registered direct offering of 1,940,299 shares and pre-funded warrants, plus private placement of 1,940,299 warrants.
- Private placement warrants priced at $0.125 each, exercise price $1.55, 3-year term from initial exercise date; subject to registration.
- Existing warrants (exp. Oct 2027) exercise price reduced from $3.30 to $1.55 effective Jan 27, 2023.
- Executives, directors and 10%+ holders subject to 90-day lock-up from closing date (Jan 31, 2023).
- Net proceeds to be used for working capital and general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1644963/000110465923008989/0001104659-23-008989-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1644963/000110465923008989/tm234660d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-008989

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer